Abstract
The activation, clonal expansion and terminal differentiation of small resting B lymphocytes primed by an antigen (or antibodies to its receptors) appear to follow an orderly developmental sequence triggered at each stage by distinct soluble cytokines, primarily produced by T lymphocytes1,2. For man, the only known B-cell mitogen independent of accessory cells for its action is the Epstein–Barr virus (EBV). Lymphocytes transformed by EBV are released from the usual constraints on B-cell growth, proliferating continuously in the absence of any exogenous cytokine3. The resultant cell lines are of special interest as they possess certain features compatible with a preneoplastic state of Burkitt's lymphoma, one of two human cancers with which the virus is intimately associated3. We report here that following EBV-transformation, B lympho-blasts release a soluble factor which mimics the B-cell stimulatory product(s) of mitogen-conditioned T lymphocytes. Furthermore, the virally-transformed cells utilize this activity to sustain their own growth. The ectopic production of an otherwise normal growth factor may represent a critical event in the malignant evolution of human lymphomas harbouring the EBV genome.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andersson, J. & Melchers, F. Proc. natn. Acad. Sci. U.S.A. 78, 2479–2501 (1981).
Howard, M. & Paul, W. E. A. Rev. Immun. 1, 307–333 (1983).
Nilsson, K. & Klein, G. Adv. Cancer Res. 37, 319–380 (1982).
Maruguchi, A., Butler, J. L., Kehrl, J. H. & Fauci, A. S. J. exp. Med. 157, 530–546 (1983).
Gordon, J., Ley, S. C., Melamed, M. D., Aman, P. & Hughes-Jones, N. C. J. exp. Med. 159, 1554–1559 (1984).
Blazar, B. A., Sutton, L. M. & Strome, M. Cancer Res. 43, 4562–4569 (1983).
Maizel, A. et al. Proc. natn. Acad. Sci. U.S.A. 79, 5998–6002 (1982).
Uittenbogaart, C. H. & Fahey, J. L. Proc. natn. Acad. Sci. U.S.A. 79, 7004–7008 (1982).
Twardzik, D. R. et al. Science 216, 894–897 (1982).
Kaplan, P. L., Anderson, M. & Ozanne, B. Proc. natn. Acad. Sci. U.S.A. 79, 485–489 (1982).
Anzano, M. A. et al. Proc. natn. Acad. Sci. U.S.A. 80, 6204–6268 (1983).
Robbins, K. C. et al. Nature 305, 605–608 (1983).
Waterfield, M. C. et al. Nature 304, 35–39 (1983).
Downward, J et al. Nature 307, 521–527 (1984).
Brickell, P. M. et al. Nature 306, 756–760 (1983).
Bernards, R. et al. Nature 305, 776–779 (1983).
Klein, G. Cell 32, 311–315 (1983).
Perry, R. P. Cell 33, 647–649 (1983).
Rabbits, T. H., Hamlyn, P. H. & Baer, R. Nature 306, 760–765 (1983).
Gordon, J., Melamed, M. D., Ley, S. C. & Hughes-Jones, N. C. Immunology 52, 79–85 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gordon, J., Ley, S., Melamed, M. et al. Immortalized B lymphocytes produce B-cell growth factor. Nature 310, 145–147 (1984). https://doi.org/10.1038/310145a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/310145a0
This article is cited by
-
Autocrine lymphotoxin production in Epstein–Barr virus-immortalized B cells: induction via NF-κB activation mediated by EBV-derived latent membrane protein 1
Leukemia (2003)
-
Physiological enhancement of immunoglobulin production of hybridomas in serum-free media
Cytotechnology (1991)
-
Stimulation of proliferation and immunoglobulin M production by lactoferrin in human-human and mouse-mouse hybridomas cultures in serum-free conditions
Cytotechnology (1990)
-
Low Affinity IgE Receptors (Fcε RII)
Clinical Reviews in Allergy (1989)
-
Partial purification and characterization of immunoglobulin production stimulating factor derived from namalwa cells
In Vitro Cellular & Developmental Biology (1989)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
